BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 30143587)

  • 1. Sialic Acid Ligand Binding of CD22 and Siglec-G Determines Distinct B Cell Functions but Is Dispensable for B Cell Tolerance Induction.
    Özgör L; Meyer SJ; Korn M; Terörde K; Nitschke L
    J Immunol; 2018 Oct; 201(7):2107-2116. PubMed ID: 30143587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD22 and Siglec-G regulate inhibition of B-cell signaling by sialic acid ligand binding and control B-cell tolerance.
    Nitschke L
    Glycobiology; 2014 Sep; 24(9):807-17. PubMed ID: 25002414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B Cell Siglecs-News on Signaling and Its Interplay With Ligand Binding.
    Meyer SJ; Linder AT; Brandl C; Nitschke L
    Front Immunol; 2018; 9():2820. PubMed ID: 30559744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice.
    Matsubara N; Imamura A; Yonemizu T; Akatsu C; Yang H; Ueki A; Watanabe N; Abdu-Allah H; Numoto N; Takematsu H; Kitazume S; Tedder TF; Marth JD; Ito N; Ando H; Ishida H; Kiso M; Tsubata T
    Front Immunol; 2018; 9():820. PubMed ID: 29725338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity.
    Jellusova J; Wellmann U; Amann K; Winkler TH; Nitschke L
    J Immunol; 2010 Apr; 184(7):3618-27. PubMed ID: 20200274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Murine Red Blood Cells Lack Ligands for B Cell Siglecs, Allowing Strong Activation by Erythrocyte Surface Antigens.
    Spiller F; Nycholat CM; Kikuchi C; Paulson JC; Macauley MS
    J Immunol; 2018 Feb; 200(3):949-956. PubMed ID: 29288201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22.
    Pfrengle F; Macauley MS; Kawasaki N; Paulson JC
    J Immunol; 2013 Aug; 191(4):1724-31. PubMed ID: 23836061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sialic acids and autoimmune disease.
    Mahajan VS; Pillai S
    Immunol Rev; 2016 Jan; 269(1):145-61. PubMed ID: 26683151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions.
    Nitschke L
    Immunol Rev; 2009 Jul; 230(1):128-43. PubMed ID: 19594633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand Recognition Determines the Role of Inhibitory B Cell Co-receptors in the Regulation of B Cell Homeostasis and Autoimmunity.
    Tsubata T
    Front Immunol; 2018; 9():2276. PubMed ID: 30333834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ligand interactions of B cell Siglecs are involved in the prevention of autoimmunity to sialylated self-antigens and in the quality control of signaling-competent B cells.
    Tsubata T
    Int Immunol; 2023 Oct; 35(10):461-473. PubMed ID: 37504378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ligand-binding domain of Siglec-G is crucial for its selective inhibitory function on B1 cells.
    Hutzler S; Özgör L; Naito-Matsui Y; Kläsener K; Winkler TH; Reth M; Nitschke L
    J Immunol; 2014 Jun; 192(11):5406-14. PubMed ID: 24790146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CD22 and Siglec-G in B-cell tolerance and autoimmune disease.
    Müller J; Nitschke L
    Nat Rev Rheumatol; 2014 Jul; 10(7):422-8. PubMed ID: 24763061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Siglec-G Deficiency Leads to Autoimmunity in Aging C57BL/6 Mice.
    Müller J; Lunz B; Schwab I; Acs A; Nimmerjahn F; Daniel C; Nitschke L
    J Immunol; 2015 Jul; 195(1):51-60. PubMed ID: 25987743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Siglec-G is a B-1 cell inhibitory receptor and also controls B cell tolerance.
    Nitschke L
    Ann N Y Acad Sci; 2015 Dec; 1362():117-21. PubMed ID: 26194636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proximity labeling of cis-ligands of CD22/Siglec-2 reveals stepwise α2,6 sialic acid-dependent and -independent interactions.
    Alborzian Deh Sheikh A; Akatsu C; Imamura A; Abdu-Allah HHM; Takematsu H; Ando H; Ishida H; Tsubata T
    Biochem Biophys Res Commun; 2018 Jan; 495(1):854-859. PubMed ID: 29146181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo.
    Duong BH; Tian H; Ota T; Completo G; Han S; Vela JL; Ota M; Kubitz M; Bovin N; Paulson JC; Nemazee D
    J Exp Med; 2010 Jan; 207(1):173-87. PubMed ID: 20038598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of B cell functions by the sialic acid-binding receptors siglec-G and CD22.
    Jellusova J; Nitschke L
    Front Immunol; 2011; 2():96. PubMed ID: 22566885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transitional and marginal zone B cells have a high proportion of unmasked CD22: implications for BCR signaling.
    Danzer CP; Collins BE; Blixt O; Paulson JC; Nitschke L
    Int Immunol; 2003 Oct; 15(10):1137-47. PubMed ID: 13679384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD22 ligand-binding and signaling domains reciprocally regulate B-cell Ca2+ signaling.
    Müller J; Obermeier I; Wöhner M; Brandl C; Mrotzek S; Angermüller S; Maity PC; Reth M; Nitschke L
    Proc Natl Acad Sci U S A; 2013 Jul; 110(30):12402-7. PubMed ID: 23836650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.